Cerluten vs Semax

Overview

Cerluten and Semax are both studied in the peptide research space.

Cerluten: A cytamin-class peptide supplement derived from brain tissue, part of the Russian bioregulator framework.

Semax: A synthetic heptapeptide analogue of ACTH(4-7) with a C-terminal Pro-Gly-Pro extension, developed by Russian researchers and approved in Russia since ~1997 for stroke, cognitive impairment, and optic nerve disorders.

Evidence Comparison

Aspect	Cerluten	Semax
Evidence Level	Low	Moderate
Human Studies	1	8
Preclinical Studies	6	24
Total Sources	8	32

Key Differences

Aspect	Cerluten	Semax
Category	Cognitive	Cognitive
Evidence Strength	Low	Moderate
Total Sources	8	32
Human Studies	1	8

Summary

• Cerluten: Low evidence with 8 total sources (1 human)
• Semax: Moderate evidence with 32 total sources (8 human)

---

This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.